Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $15.11 $17.90 Friday, 10th May 2024 ACAD stock ended at $15.25. This is 0.263% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 2.78% from a day low at $15.11 to a day high of $15.53.
90 days $15.11 $26.78
52 weeks $15.11 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Jan 04, 2017 $28.91 $32.93 $28.69 $31.94 7 005 381
Jan 03, 2017 $29.13 $29.54 $28.53 $28.77 1 332 508
Dec 30, 2016 $28.92 $29.66 $28.54 $28.84 1 415 291
Dec 29, 2016 $28.47 $29.76 $28.40 $28.79 1 658 774
Dec 28, 2016 $28.88 $29.29 $28.42 $28.52 1 321 818
Dec 27, 2016 $30.41 $30.98 $28.89 $28.95 2 857 363
Dec 23, 2016 $27.63 $29.98 $27.51 $29.75 3 467 912
Dec 22, 2016 $27.44 $28.40 $27.09 $27.67 2 036 772
Dec 21, 2016 $28.46 $28.95 $27.42 $27.46 3 964 580
Dec 20, 2016 $29.26 $30.14 $27.26 $28.57 18 508 632
Dec 19, 2016 $26.15 $26.46 $25.30 $25.43 1 144 440
Dec 16, 2016 $25.72 $26.51 $25.65 $25.98 2 089 544
Dec 15, 2016 $24.96 $26.07 $24.82 $26.01 1 853 572
Dec 14, 2016 $24.79 $25.23 $24.31 $24.94 1 608 147
Dec 13, 2016 $25.30 $25.64 $24.71 $24.87 1 499 667
Dec 12, 2016 $26.60 $26.80 $25.05 $25.28 2 046 344
Dec 09, 2016 $27.22 $27.84 $26.61 $26.76 1 409 849
Dec 08, 2016 $26.88 $27.47 $26.47 $27.24 1 394 777
Dec 07, 2016 $27.61 $27.85 $26.27 $27.08 1 969 609
Dec 06, 2016 $27.77 $28.34 $27.17 $28.25 1 038 146
Dec 05, 2016 $27.68 $28.78 $27.33 $27.79 1 847 892
Dec 02, 2016 $26.63 $27.66 $26.08 $27.15 1 500 226
Dec 01, 2016 $27.09 $27.48 $26.46 $26.48 1 843 488
Nov 30, 2016 $27.74 $28.27 $26.97 $26.99 1 462 870
Nov 29, 2016 $27.41 $28.13 $27.03 $27.65 1 153 893
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT